Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma

por Pietrobono, Silvia, Gaudio, Eugenio, Gagliardi, Sinforosa, Zitani, Mariapaola, Carrassa, Laura, Migliorini, Francesca, Petricci, Elena, Manetti, Fabrizio, Makukhin, Nikolai, Bond, Adam G., Paradise, Brooke D., Ciulli, Alessio, Fernandez-Zapico, Martin E., Bertoni, Francesco, Stecca, Barbara
Publicado 2021